Ignite Creation Date:
2024-05-05 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00436566
Status:
COMPLETED
Last Update Posted:
2022-08-05
First Post:
2007-02-15
Brief Title:
Doxorubicin and Cyclophosphamide Followed By Trastuzumab Paclitaxel and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic